420 related articles for article (PubMed ID: 25532939)
1. Pediatric low-grade fibromyxoid sarcoma mimicking ossifying fibromyxoid tumor: adding to the diagnostic spectrum of soft tissue tumors with a bony shell.
Thway K; Chisholm J; Hayes A; Swansbury J; Fisher C
Hum Pathol; 2015 Mar; 46(3):461-6. PubMed ID: 25532939
[TBL] [Abstract][Full Text] [Related]
2. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.
Doyle LA; Wang WL; Dal Cin P; Lopez-Terrada D; Mertens F; Lazar AJ; Fletcher CD; Hornick JL
Am J Surg Pathol; 2012 Oct; 36(10):1444-51. PubMed ID: 22982887
[TBL] [Abstract][Full Text] [Related]
3. DOG1 Expression in Low-Grade Fibromyxoid Sarcoma: A Study of 11 Cases, With Molecular Characterization.
Thway K; Ng W; Benson C; Chapman J; Fisher C
Int J Surg Pathol; 2015 Sep; 23(6):454-60. PubMed ID: 26135531
[TBL] [Abstract][Full Text] [Related]
4. Low-grade fibromyxoid sarcoma: Clinical, morphologic and genetic features.
Mohamed M; Fisher C; Thway K
Ann Diagn Pathol; 2017 Jun; 28():60-67. PubMed ID: 28648941
[TBL] [Abstract][Full Text] [Related]
5. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma.
Doyle LA; Möller E; Dal Cin P; Fletcher CD; Mertens F; Hornick JL
Am J Surg Pathol; 2011 May; 35(5):733-41. PubMed ID: 21415703
[TBL] [Abstract][Full Text] [Related]
6. FUS (16p11) gene rearrangement as detected by fluorescence in-situ hybridization in cutaneous low-grade fibromyxoid sarcoma: a potential diagnostic tool.
Patel RM; Downs-Kelly E; Dandekar MN; Fanburg-Smith JC; Billings SD; Tubbs RR; Goldblum JR
Am J Dermatopathol; 2011 Apr; 33(2):140-3. PubMed ID: 21399449
[TBL] [Abstract][Full Text] [Related]
7. Recurrent EWSR1-CREB3L1 gene fusions in sclerosing epithelioid fibrosarcoma.
Arbajian E; Puls F; Magnusson L; Thway K; Fisher C; Sumathi VP; Tayebwa J; Nord KH; Kindblom LG; Mertens F
Am J Surg Pathol; 2014 Jun; 38(6):801-8. PubMed ID: 24441665
[TBL] [Abstract][Full Text] [Related]
8. The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma.
Panagopoulos I; Storlazzi CT; Fletcher CD; Fletcher JA; Nascimento A; Domanski HA; Wejde J; Brosjö O; Rydholm A; Isaksson M; Mandahl N; Mertens F
Genes Chromosomes Cancer; 2004 Jul; 40(3):218-28. PubMed ID: 15139001
[TBL] [Abstract][Full Text] [Related]
9. Low-grade fibromyxoid sarcoma arising in the big toe.
Kusumi T; Nishikawa S; Tanaka M; Ogawa T; Jin H; Sato F; Toh S; Hasegawa T; Kijima H
Pathol Int; 2005 Dec; 55(12):802-6. PubMed ID: 16287497
[TBL] [Abstract][Full Text] [Related]
10. Ossifying fibromyxoid tumor: a clinicopathologic analysis of 26 subcutaneous tumors with emphasis on differential diagnosis and prognostic factors.
Atanaskova Mesinkovska N; Buehler D; McClain CM; Rubin BP; Goldblum JR; Billings SD
J Cutan Pathol; 2015 Sep; 42(9):622-31. PubMed ID: 25950586
[TBL] [Abstract][Full Text] [Related]
11. Low-grade fibromyxoid sarcoma with nuclear pleomorphism arising in the subcutis of a child.
Sedrak MP; Parker DC; Gardner JM
J Cutan Pathol; 2014 Feb; 41(2):134-8. PubMed ID: 24188507
[TBL] [Abstract][Full Text] [Related]
12. Molecular detection of FUS-CREB3L2 fusion transcripts in low-grade fibromyxoid sarcoma using formalin-fixed, paraffin-embedded tissue specimens.
Matsuyama A; Hisaoka M; Shimajiri S; Hayashi T; Imamura T; Ishida T; Fukunaga M; Fukuhara T; Minato H; Nakajima T; Yonezawa S; Kuroda M; Yamasaki F; Toyoshima S; Hashimoto H
Am J Surg Pathol; 2006 Sep; 30(9):1077-84. PubMed ID: 16931951
[TBL] [Abstract][Full Text] [Related]
13. Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group.
Guillou L; Benhattar J; Gengler C; Gallagher G; Ranchère-Vince D; Collin F; Terrier P; Terrier-Lacombe MJ; Leroux A; Marquès B; Aubain Somerhausen Nde S; Keslair F; Pedeutour F; Coindre JM
Am J Surg Pathol; 2007 Sep; 31(9):1387-402. PubMed ID: 17721195
[TBL] [Abstract][Full Text] [Related]
14. Primary low-grade fibromyxoid sarcoma of the kidney in a child with the alternative EWSR1-CREB3L1 gene fusion.
Rubinstein JC; Visa A; Zhang L; Antonescu CR; Christison-Lagay ER; Morotti R
Pediatr Dev Pathol; 2014; 17(4):321-6. PubMed ID: 24896634
[TBL] [Abstract][Full Text] [Related]
15. Ossifying fibromyxoid tumor: morphology, genetics, and differential diagnosis.
Schneider N; Fisher C; Thway K
Ann Diagn Pathol; 2016 Feb; 20():52-8. PubMed ID: 26732302
[TBL] [Abstract][Full Text] [Related]
16. Intramuscular low-grade fibromyxoid sarcoma: a case report.
Liao KS; Huang WT; Yang SF; Chien SH; Hsieh TJ; Chai CY; Wu CC
Kaohsiung J Med Sci; 2009 Aug; 25(8):448-54. PubMed ID: 19605340
[TBL] [Abstract][Full Text] [Related]
17. EWSR1-CREB3L1 gene fusion: a novel alternative molecular aberration of low-grade fibromyxoid sarcoma.
Lau PP; Lui PC; Lau GT; Yau DT; Cheung ET; Chan JK
Am J Surg Pathol; 2013 May; 37(5):734-8. PubMed ID: 23588368
[TBL] [Abstract][Full Text] [Related]
18. [Ossifying fibromyxoid tumor].
Makhson AN; Bulycheva IV; Kuz'min IV; Denisov AK; Groshev IA
Arkh Patol; 2006; 68(2):41-4. PubMed ID: 16752509
[TBL] [Abstract][Full Text] [Related]
19. [Low-grade fibromyxoid sarcoma, an essential differential diagnosis in myxoid tumors with benign appearance].
Alfaro-Cervelló C; Benavent Casanova O; Nieto G; Mares Diago FJ; Navarro S
Rev Esp Patol; 2018; 51(3):178-182. PubMed ID: 30012311
[TBL] [Abstract][Full Text] [Related]
20. Expanding the molecular signature of ossifying fibromyxoid tumors with two novel gene fusions: CREBBP-BCORL1 and KDM2A-WWTR1.
Kao YC; Sung YS; Zhang L; Chen CL; Huang SC; Antonescu CR
Genes Chromosomes Cancer; 2017 Jan; 56(1):42-50. PubMed ID: 27537276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
